Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network.

Chinese medicine has been widely used in clinical practice, but its mode of action often remains obscure. This has seriously hindered further development and better clinical applications of Chinese medicine. Among the most critical questions to be addressed, the identification of active ingredients is an important one requiring more research. Existing methods are only concerned the potential pharmacological effects of the individual purified chemical ingredients without consideration of the contents of these ingredients, which is critical to the comprehensive effect of Chinese medicine. A novel approach was proposed here to integrate network pharmacology analysis and ingredient content in Chinese medicine to identify active ingredients. The therapeutic action of Xuesaitong (XST) injection on myocardial infarction was analyzed as an example in this study. Firstly, we built a cardiovascular disease (CVD) related protein-protein interaction (PPI) network. Secondly, the potential targets of the ingredients of XST were identified by integrating microarray data, text mining and pharmacophore model-based prediction. The target-ingredient relationships were then mapped to the network. Topological attributes related to the targets of these ingredients, together with the ingredients' contents, were combined to calculate a composition-weighted index for integrative evaluation of ingredient efficacy. Our results indicated that major active ingredients in XST were notoginsenoside R1, ginsenoside Rg1, Rb1, Rd and Re, which was further validated on myocardial infarction rat models. In conclusion, this study presented a novel approach to identify active ingredients in Chinese medicine.

[1]  F. Cheung TCM: Made in China , 2011, Nature.

[2]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[3]  Jong-Hoon Kim,et al.  Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach , 2013, Journal of ginseng research.

[4]  Peter J. Tonellato,et al.  Rat Genome Database (RGD): mapping disease onto the genome , 2002, Nucleic Acids Res..

[5]  Andrew Jenner,et al.  Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines. , 2004, Free radical biology & medicine.

[6]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[7]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[8]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[9]  Kai Huang,et al.  PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..

[10]  Yi Wang,et al.  A Network Pharmacology Approach to Evaluating the Efficacy of Chinese Medicine Using Genome-Wide Transcriptional Expression Data , 2013, Evidence-based complementary and alternative medicine : eCAM.

[11]  Melinda R. Dwinell,et al.  The Rat Genome Database 2013—data, tools and users , 2013, Briefings Bioinform..

[12]  Qing Shao,et al.  Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS , 2011, Chinese medicine.

[13]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[14]  Jun Xu,et al.  Chinese herbal medicine and acupuncture for the treatment of cardiovascular disease , 2009 .

[15]  Zhi Wang,et al.  Ginsenoside Rb1 Preconditioning Protects Against Myocardial Infarction After Regional Ischemia and Reperfusion by Activation of Phosphatidylinositol-3-kinase Signal Transduction , 2008, Cardiovascular Drugs and Therapy.

[16]  Xiaowei Xu,et al.  Constructing a robust protein-protein interaction network by integrating multiple public databases , 2011, BMC Bioinformatics.

[17]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[18]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[19]  R. Bauer,et al.  Phytochemistry and pharmacogenomics of natural products derived from traditional chinese medicine and chinese materia medica with activity against tumor cells , 2008, Molecular Cancer Therapeutics.

[20]  Yan Yu-zhen,et al.  Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction , 2005 .

[21]  Feng Gao,et al.  Ginsenoside Rd Attenuates Myocardial Ischemia/Reperfusion Injury via Akt/GSK-3β Signaling and Inhibition of the Mitochondria-Dependent Apoptotic Pathway , 2013, PloS one.

[22]  Y. Tu The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine , 2011, Nature Medicine.

[23]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[24]  Yong Jiang,et al.  Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. , 2013, Journal of Ethnopharmacology.

[25]  Noel M. O'Boyle,et al.  De novo design of molecular wires with optimal properties for solar energy conversion , 2011, J. Cheminformatics.

[26]  Chenguang Zhang,et al.  Spirituality in Traditional Chinese Medicine , 2012 .

[27]  Wei Liu,et al.  A Network Study of Chinese Medicine Xuesaitong Injection to Elucidate a Complex Mode of Action with Multicompound, Multitarget, and Multipathway , 2013, Evidence-based complementary and alternative medicine : eCAM.

[28]  E. Braunwald,et al.  A tale of coronary artery disease and myocardial infarction. , 2012, The New England journal of medicine.

[29]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[30]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[31]  D. Kremastinos,et al.  Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits. , 2000, Atherosclerosis.

[32]  Fulong Liao,et al.  Chinese medicine, flowing blood, biomechanopharmacology and future preventive medicine , 2012 .

[33]  Tiejun Cheng,et al.  Characterizing protein domain associations by Small-molecule ligand binding. , 2012, Journal of proteome science and computational biology.

[34]  Axel Drefahl,et al.  CurlySMILES: a chemical language to customize and annotate encodings of molecular and nanodevice structures , 2011, J. Cheminformatics.